Caixin Global – Latest China News & Headlines

Home >


CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

Ping An-Affiliated Fintech Firm OneConnect Raises Capital from New Share Sale As It Eyes Global Expansion
Pompeo Hints At ‘Broader’ Ban on Chinese Apps After Trump’s Executive Orders Targeting TikTok and WeChat
Trending in China: Merchants and Netizens Forced to Pick Sides in Fight Between Delivery Firms
Baidu-Backed Video Streamer iQiyi Probed by U.S. Regulator After Short Seller’s Report
AI Unicorn SenseTime Is Said to Mull Hong Kong, China IPO
Huawei Copies Korean Rivals by Manufacturing Own Display Driver Integrated Chips
JOYY’s Livestreaming Revenue Up 40% in Second Quarter of 2020
Trending in China: ‘Mukbangs’ Under Fire in China Amid High Level Food Waste Campaign
Trending in China: How Will the Chinese Diaspora Survive a WeChat Ban In U.S.?
Online Platform Buys into Bricks and Mortar Convenience Store Chain
China Unicom Profits Rise in First Half, Stock Soars
ByteDance in Talks with Indian Conglomerate Over TikTok Amid Layoff Fears
Alibaba’s Zhang Yong Tops 2020 Forbes China Best CEOs List
Trending: Family Feud Raises Big Questions Over Succession in China’s Multi-Million “Family” Businesses
Shanghai-Listed Foxconn Internet’s Cloud Service Sales Up 4% in First Half of 2020
U.S.-Listed Chinese Companies Nio and Huya Have Something to Cheer About
Apple Edges Huawei Out of No. 1 in Quarterly Tablet Shipments
Chinese Finance Platform Lufax Files for U.S. IPO of up to $3 Billion
China Mainland Leads U.S. in Fortune Global 500 Companies But Trails in Profitability
Trending in China: Tencent – Fighting Youth Unemployment or Enemy of Older Workers?
Firm Gets Green Light to Grow Pot in Yunnan

By Zhao Runhua / Feb 21, 2019 06:44 PM / Business & Tech

Photo: VCG

Photo: VCG

Units of a Chinese pharmaceutical company have received approval to grow cannabis for medicinal and other industrial purposes in Yunnan province.

Subsidiaries of Zhejiang Jinhua Conba Biological will grow the marijuana plant in areas with a total size of 16 square kilometers (7.72 square miles) in Yunnan, according to a statement the company released on Wednesday.

The approved cannabis strain — a locally cultivated seed called Yunma No. 7 — will contain less THC (the psychoactive constituent of cannabis) and be more suited for industrial and medicinal purposes, the company said.

Yunnan province, in China’s southwest next to the opium-producing Golden Triangle, was first legally allowed to grow cannabis in 2010. In 2017, Heilongjiang province, near Russia, received permission. Jilin, next to North Korea, has filed to legalize cannabis plantations.

Conba’s major pharmaceutical products are gastrointestinal and pain-relieving medicines. The company's Shanghai-traded stock got high today — rising 9.93% — and increased Conba’s market cap by 1.6 billion yuan ($239 million).

Related: Chinese Delegation Heads to Israel to Explore Cannabis

Share this article
Open WeChat and scan the QR code